211 related articles for article (PubMed ID: 24971701)
1. Serum autoantibodies in pristane induced lupus are regulated by neutrophil gelatinase associated lipocalin.
Pawar RD; Goilav B; Xia Y; Zhuang H; Herlitz L; Reeves WH; Putterman C
Clin Immunol; 2014 Sep; 154(1):49-65. PubMed ID: 24971701
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-lipocalin 2 IgG is a novel biomarker in the diagnosis of systemic lupus erythematosus.
Li YN; Hu FL; Dai YJ; Li R; Ma XX; Du Y; Feng M; Jia Y; Zhang CF; Zhu L; Ascherman DP; Li ZG
Lupus; 2014 Aug; 23(9):868-75. PubMed ID: 24704774
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.
Hinze CH; Suzuki M; Klein-Gitelman M; Passo MH; Olson J; Singer NG; Haines KA; Onel K; O'Neil K; Silverman ED; Tucker L; Ying J; Devarajan P; Brunner HI
Arthritis Rheum; 2009 Sep; 60(9):2772-81. PubMed ID: 19714584
[TBL] [Abstract][Full Text] [Related]
4. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis.
Rubinstein T; Pitashny M; Putterman C
Autoimmun Rev; 2008 Jan; 7(3):229-34. PubMed ID: 18190883
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil gelatinase-associated lipocalin as a biomarker for lupus nephritis.
Torres-Salido MT; Cortés-Hernández J; Vidal X; Pedrosa A; Vilardell-Tarrés M; Ordi-Ros J
Nephrol Dial Transplant; 2014 Sep; 29(9):1740-9. PubMed ID: 24711435
[TBL] [Abstract][Full Text] [Related]
6. Relationship between neutrophil gelatinase-associated lipocalin levels and disease parameters including clinicopathological parameters and various cytokine levels in systemic lupus erythematosus.
Choi EW
J Vet Med Sci; 2023 Jun; 85(6):601-608. PubMed ID: 37088550
[TBL] [Abstract][Full Text] [Related]
7. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
8. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.
Brunner HI; Mueller M; Rutherford C; Passo MH; Witte D; Grom A; Mishra J; Devarajan P
Arthritis Rheum; 2006 Aug; 54(8):2577-84. PubMed ID: 16868980
[TBL] [Abstract][Full Text] [Related]
9. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children.
Hammad A; Mosaad Y; Elhanbly S; Youssef H; El Refaaey A; Elhusseini F; Bakr A
Lupus; 2013 Apr; 22(5):486-91. PubMed ID: 23554037
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice.
Pawar RD; Pitashny M; Gindea S; Tieng AT; Levine B; Goilav B; Campbell SR; Xia Y; Qing X; Thomas DB; Herlitz L; Berger T; Mak TW; Putterman C
Arthritis Rheum; 2012 May; 64(5):1620-31. PubMed ID: 22083497
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.
Chakraborty S; Kaur S; Muddana V; Sharma N; Wittel UA; Papachristou GI; Whitcomb D; Brand RE; Batra SK
Am J Gastroenterol; 2010 Sep; 105(9):2050-9. PubMed ID: 20179686
[TBL] [Abstract][Full Text] [Related]
13. A miniaturized immunoassay platform to measure neutrophil gelatinase-associated lipocalin (NGAL) for diagnosis of acute kidney injury.
Bovornvirakit T; Avihingsanon Y; Tiranathanagul K; Viravaidya-Pasuwat K
Biomarkers; 2013 May; 18(3):273-8. PubMed ID: 23566001
[TBL] [Abstract][Full Text] [Related]
14. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury.
Kümpers P; Hafer C; Lukasz A; Lichtinghagen R; Brand K; Fliser D; Faulhaber-Walter R; Kielstein JT
Crit Care; 2010; 14(1):R9. PubMed ID: 20122150
[TBL] [Abstract][Full Text] [Related]
15. Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus.
Yang CC; Hsieh SC; Li KJ; Wu CH; Lu MC; Tsai CY; Yu CL
J Biomed Biotechnol; 2012; 2012():759313. PubMed ID: 22500106
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
Clynes R; Calvani N; Croker BP; Richards HB
Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
[TBL] [Abstract][Full Text] [Related]
17. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock.
Wheeler DS; Devarajan P; Ma Q; Harmon K; Monaco M; Cvijanovich N; Wong HR
Crit Care Med; 2008 Apr; 36(4):1297-303. PubMed ID: 18379258
[TBL] [Abstract][Full Text] [Related]
18. [Prokaryotic expression and immunological activity of human neutrophil gelatinase associated lipocalin].
Wu J; Cai L; Qian W; Jiao L; Li J; Song X; Wang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):933-6. PubMed ID: 26146065
[TBL] [Abstract][Full Text] [Related]
19. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
[TBL] [Abstract][Full Text] [Related]
20. X-linked immunodeficient mice spontaneously produce lupus-related anti-RNA helicase A autoantibodies, but are resistant to pristane-induced lupus.
Satoh M; Mizutani A; Behney KM; Kuroda Y; Akaogi J; Yoshida H; Nacionales DC; Hirakata M; Ono N; Reeves WH
Int Immunol; 2003 Sep; 15(9):1117-24. PubMed ID: 12917264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
